Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · IEX Real-Time Price · USD
3.250
-0.080 (-2.40%)
At close: Jul 19, 2024, 4:00 PM
3.170
-0.080 (-2.46%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Heron Therapeutics Revenue
Heron Therapeutics had revenue of $132.10M in the twelve months ending March 31, 2024, with 16.05% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $34.67M with 17.07% year-over-year growth. In the year 2023, Heron Therapeutics had annual revenue of $127.04M with 17.99% growth.
Revenue (ttm)
$132.10M
Revenue Growth
+16.05%
P/S Ratio
3.71
Revenue / Employee
$1,048,405
Employees
126
Market Cap
489.62M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 127.04M | 19.37M | 17.99% |
Dec 31, 2022 | 107.67M | 21.33M | 24.70% |
Dec 31, 2021 | 86.35M | -2.29M | -2.59% |
Dec 31, 2020 | 88.64M | -57.33M | -39.28% |
Dec 31, 2019 | 145.97M | 68.49M | 88.41% |
Dec 31, 2018 | 77.47M | 46.71M | 151.81% |
Dec 31, 2017 | 30.77M | 29.49M | 2,305.55% |
Dec 31, 2016 | 1.28M | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 0 | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 646.00K | -655.00K | -50.35% |
Dec 31, 2010 | 1.30M | 40.00K | 3.17% |
Dec 31, 2009 | 1.26M | 892.00K | 241.73% |
Dec 31, 2008 | 369.00K | -43.00K | -10.44% |
Dec 31, 2007 | 412.00K | - | - |
Dec 31, 2006 | 0 | - | - |
Dec 31, 2005 | 5.39M | -13.00K | -0.24% |
Dec 31, 2004 | 5.40M | 556.00K | 11.47% |
Dec 31, 2003 | 4.85M | 178.00K | 3.81% |
Dec 31, 2002 | 4.67M | 1.41M | 43.03% |
Dec 31, 2001 | 3.27M | -101.00K | -3.00% |
Dec 31, 2000 | 3.37M | -1.33M | -28.33% |
Dec 31, 1999 | 4.70M | 1.62M | 52.77% |
Dec 31, 1998 | 3.07M | -14.13M | -82.13% |
Dec 31, 1997 | 17.21M | -453.96K | -2.57% |
Dec 31, 1996 | 17.66M | 1.55M | 9.64% |
Dec 31, 1995 | 16.11M | 223.75K | 1.41% |
Dec 31, 1994 | 15.88M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sharecare | 419.82M |
Treace Medical Concepts | 196.03M |
biote | 187.32M |
Y-mAbs Therapeutics | 84.50M |
Jin Medical International | 19.82M |
Fate Therapeutics | 6.48M |
Fulcrum Therapeutics | 2.51M |
Oculis Holding AG | 995.46K |
HRTX News
- 6 days ago - Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System - PRNewsWire
- 19 days ago - Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") - PRNewsWire
- 7 weeks ago - Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN") - PRNewsWire
- 2 months ago - Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates - PRNewsWire
- 3 months ago - Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - PRNewsWire
- 3 months ago - Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City - PRNewsWire
- 4 months ago - Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference - PRNewsWire
- 4 months ago - Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates - PRNewsWire